BioSig Technologies to Speak at Digital Silver Forum in Helsinki, Finland on November 28
08 nov. 2017 08h00 HE
|
BioSig Technologies, Inc.
Santa Monica, CA, Nov. 08, 2017 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (OTCQB: BSGM), a medical device company developing a proprietary biomedical signal processing platform designed to...
BioSig Technologies Partners with Sherpa Technology Group
02 nov. 2017 08h00 HE
|
BioSig Technologies, Inc.
Santa Monica, CA, Nov. 02, 2017 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (OTCQB: BSGM), a medical device company developing a proprietary platform designed to address an unmet technology need...
BioSig Technologies Announces Results of Independent Product Assessment Study for PURE EP System
26 oct. 2017 08h00 HE
|
BioSig Technologies, Inc.
Minneapolis, MN, Oct. 26, 2017 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (OTCQB: BSGM), a medical device company developing a proprietary platform designed to address an unmet technology need...
BioSig Technologies Adds Role of Manufacturing Project Leader as Company Continues to Advance Towards Commercialization
24 oct. 2017 08h00 HE
|
BioSig Technologies, Inc.
Minneapolis, MN, Oct. 24, 2017 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (OTCQB: BSGM), a medical device company developing a proprietary platform designed to address an unmet technology need...
BioSig Technologies Advances Towards Commercialization into the Global Electrophysiology Market Estimated to Reach $8.2 Billion by 2022
19 oct. 2017 08h00 HE
|
BioSig Technologies, Inc.
Minneapolis, MN, Oct. 19, 2017 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (BSGM), a medical device company developing a proprietary platform designed to address an unmet technology need within...
BioSig Technologies to Present at the Dawson James Small Cap Growth Conference
13 oct. 2017 08h00 HE
|
BioSig Technologies, Inc.
Minneapolis, MN, Oct. 13, 2017 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (OTCQB: BSGM), a medical device company developing a proprietary platform designed to address an unmet technology need...
BioSig Technologies Welcomes Joseph W. Rafferty as Chief Commercialization Officer
11 oct. 2017 08h00 HE
|
BioSig Technologies, Inc.
Minneapolis, MN, Oct. 11, 2017 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (OTCQB: BSGM), a medical device company developing a proprietary platform designed to address an unmet technology need...
Novel Findings Obtained with the PURE EP System to be Presented at American Heart Association’s BCVS Scientific Sessions 2017
26 juin 2017 08h00 HE
|
BioSig Technologies, Inc.
Minneapolis, MN, June 26, 2017 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (OTCQB: BSGM), a medical device company developing a proprietary platform designed to address an unmet technology need...
BioSig Technologies’ CEO, Ken Londoner Interviewed by Medgadget
13 juin 2017 08h00 HE
|
BioSig Technologies, Inc.
Minneapolis, MN, June 13, 2017 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (OTCQB: BSGM), a medical device company developing a proprietary platform designed to address an unmet technology need...
BioSig Technologies Launches New Corporate Website
08 juin 2017 08h00 HE
|
BioSig Technologies, Inc.
Minneapolis, MN, June 08, 2017 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (OTCQB: BSGM), a medical device company developing a proprietary platform designed to address an unmet technology need...